Literature DB >> 6207023

Acetylcholine-like effects of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine ('platelet-activating factor') and its analogues in exocrine secretory glands.

H D Söling, H Eibl, W Fest.   

Abstract

The effect of 1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine (1), 1-O-octadecyl-2-acetyl-sn-glycero-3-phosphocholine (2) 1-O-hexadecyl-sn-glycero-3-phosphocholine (3), 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine (4) and its enantiomer 3-O-octadecyl-2-O-methyl-sn-glycero-1-phosphocholine (5) on the secretion of amylase from guinea pig isolated parotid gland and exocrine pancreatic lobules was examined. Compounds 1, 2 and 4 led to a significant stimulation of amylase release in both systems, effects being already visible between 10-100 pM. Maximal stimulation with compounds 1 and 2 occurred at 5 nM, with compound 4 at 1 nM. Higher concentrations were less effective and at 0.1 microM stimulation was very low. In contrast, compound 5 showed a continuous increase in activity up to 0.01-0.1 microM without a decrease at at higher concentrations. Compound 3 had no effect. For compound 1, its effects on calcium and lipid metabolism have been analyzed and compared with those of the acetylcholine analogue carbamoylcholine. Compound 1 mimicked in every respect the effects of carbamoylcholine. It stimulated the uptake of 45Ca by isolated parotid gland lobules in a non-ionophoretic way. In isolated pancreatic lobules it enhanced the incorporation of [32P]phosphate into phosphatidic acid, phosphatidylinositol and poly(phosphoinositide), increased the formation of diacylglycerols and triacylglycerol, led to the same two-phasic responses of myo-[3H]inositol-labeled polyphosphoinositides, and initiated a rapid short-lasting formation of free inositol triphosphate. Accordingly, 'platelet activating factor(s)' can affect the function of exocrine glands at low concentrations. The effects observed resemble those produced by acetylcholine and result most likely from the interaction of platelet-activating factor with plasma membrane receptors.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6207023     DOI: 10.1111/j.1432-1033.1984.tb08431.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  12 in total

1.  The effect of platelet activating factor antagonist (BN 52021) on cerulein-induced acute pancreatitis with reference to oxygen radicals.

Authors:  A Dabrowski; A Gabryelewicz; L Chyczewski
Journal:  Int J Pancreatol       Date:  1991-01

2.  Calcium-dependent biosynthesis of platelet-activating factor by submandibular gland cells.

Authors:  T Dohi; K Morita; S Kitayama; A Tsujimoto
Journal:  Biochem J       Date:  1991-05-15       Impact factor: 3.857

3.  Role of endogenous platelet-activating factor in the regulation of pancreatic blood flow during caerulein stimulation.

Authors:  M Ogura; Y Kubota; K Inoue
Journal:  J Gastroenterol       Date:  1996-06       Impact factor: 7.527

Review 4.  Inositol phospholipid turnover in PAF transmembrane signalling.

Authors:  S D Shukla
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

5.  Experimental acute pancreatitis induced by platelet activating factor in rabbits.

Authors:  G Emanuelli; G Montrucchio; E Gaia; L Dughera; G Corvetti; L Gubetta
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

6.  Biosynthesis of platelet-activating factor in glandular gastric mucosa. Evidence for the involvement of the 'de novo' pathway and modulation by fatty acids.

Authors:  S Fernandez-Gallardo; M A Gijon; M C Garcia; E Cano; M Sanchez Crespo
Journal:  Biochem J       Date:  1988-09-15       Impact factor: 3.857

7.  Platelet-activating factor: a mediator of pancreatic inflammation during cerulein hyperstimulation.

Authors:  W Zhou; B A Levine; M S Olson
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

8.  Role of platelet activating factor in pathogenesis of acute pancreatitis in rats.

Authors:  S J Konturek; A Dembinski; P J Konturek; Z Warzecha; J Jaworek; P Gustaw; R Tomaszewska; J Stachura
Journal:  Gut       Date:  1992-09       Impact factor: 23.059

9.  Influence of a platelet-activating factor antagonist on severe pancreatitis in two experimental models.

Authors:  U Leonhardt; A Fayyazzi; F Seidensticker; F Stöckmann; H D Söling; W Creutzfeldt
Journal:  Int J Pancreatol       Date:  1992-10

Review 10.  The pathophysiological role and therapeutic implications of platelet activating factor in diseases of aging.

Authors:  C Kroegel; C Kortsik; N Kroegel; H Matthys
Journal:  Drugs Aging       Date:  1992 Jul-Aug       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.